Review



d18 1 d7 15 0 lactosylceramide  (Croda International Plc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 91
      Buy from Supplier

    Structured Review

    Croda International Plc d18 1 d7 15 0 lactosylceramide
    D18 1 D7 15 0 Lactosylceramide, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 91/100, based on 31 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d18+1+d7+15+0+lactosylceramide/C15+Lactosyl(%CE%B2)+Ceramide-d7/pmc12818558-974-0-3
    Average 91 stars, based on 31 article reviews
    d18 1 d7 15 0 lactosylceramide - by Bioz Stars, 2026-10
    91/100 stars

    Images

    Related Articles

    other:

    Article Title: 1-Deoxysphingolipids dysregulate membrane properties and cargo trafficking in the early secretory pathway
    Article Snippet: d18:1-d7/15:0 lactosylceramide , Avanti Polar Lipids , Cat# 330727.



    Similar Products

    d18 1 d7 15 0 lactosylceramide  (Croda International Plc)
    91
    Croda International Plc d18 1 d7 15 0 lactosylceramide
    D18 1 D7 15 0 Lactosylceramide, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d18+1+d7+15+0+lactosylceramide/C15+Lactosyl(%CE%B2)+Ceramide-d7/pmc12818558-974-0-3
    Average 91 stars, based on 1 article reviews
    d18 1 d7 15 0 lactosylceramide - by Bioz Stars, 2026-10
    91/100 stars
    		  Buy from Supplier
    d18:1-d7/15:0 lactosylceramide  (Croda International Plc)
    90
    Croda International Plc d18:1-d7/15:0 lactosylceramide
    D18:1 D7/15:0 Lactosylceramide, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d18+1+d7+15+0+lactosylceramide/sm+d18+1+12+0/pm36697822-450-93-95
    Average 90 stars, based on 1 article reviews
    d18:1-d7/15:0 lactosylceramide - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    lactosylceramide (d18:1-d7/15:0  (Avanti Inc)
    90
    Avanti Inc lactosylceramide (d18:1-d7/15:0
    ( A ) Schematic of major plasma lipids. ( B ) Concentration of plasma cholesterol in WT and Polg mice. Concentration of total ( C ) and individual ( D ) plasma fatty acids in WT and Polg mice. Abundance of plasma triacylglycerols ( E ) and diacylglycerols ( F ), phosphatidylethanolamine (PE) ( G ), and phosphatidylcholine (PC) ( H ) relative to internal standard per microliter of plasma in WT and Polg mice. Concentration of plasma dihydroceramide ( I ), ceramide ( J ), sphingomyelin ( K ), glucosylceramide ( L ), and <t>lactosylceramide</t> ( M ) in WT and Polg mice. Two-sided Student’s t test for each comparison with no adjustment for multiple comparisons. Data are means ± SEM of n = 7 to 8 animals per group. * P < 0.05, ** P < 0.01, and **** P < 0.0001.
    Lactosylceramide (D18:1 D7/15:0, supplied by Avanti Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d18+1+d7+15+0+lactosylceramide/c15+ceramide+d7++d18+1+d7+15+0/pmc08519573-243-101-103
    Average 90 stars, based on 1 article reviews
    lactosylceramide (d18:1-d7/15:0 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A ) Schematic of major plasma lipids. ( B ) Concentration of plasma cholesterol in WT and Polg mice. Concentration of total ( C ) and individual ( D ) plasma fatty acids in WT and Polg mice. Abundance of plasma triacylglycerols ( E ) and diacylglycerols ( F ), phosphatidylethanolamine (PE) ( G ), and phosphatidylcholine (PC) ( H ) relative to internal standard per microliter of plasma in WT and Polg mice. Concentration of plasma dihydroceramide ( I ), ceramide ( J ), sphingomyelin ( K ), glucosylceramide ( L ), and lactosylceramide ( M ) in WT and Polg mice. Two-sided Student’s t test for each comparison with no adjustment for multiple comparisons. Data are means ± SEM of n = 7 to 8 animals per group. * P < 0.05, ** P < 0.01, and **** P < 0.0001.

    Journal: Science Advances

    Article Title: Progressive alterations in amino acid and lipid metabolism correlate with peripheral neuropathy in Polg D257A mice

    doi: 10.1126/sciadv.abj4077

    Figure Lengend Snippet: ( A ) Schematic of major plasma lipids. ( B ) Concentration of plasma cholesterol in WT and Polg mice. Concentration of total ( C ) and individual ( D ) plasma fatty acids in WT and Polg mice. Abundance of plasma triacylglycerols ( E ) and diacylglycerols ( F ), phosphatidylethanolamine (PE) ( G ), and phosphatidylcholine (PC) ( H ) relative to internal standard per microliter of plasma in WT and Polg mice. Concentration of plasma dihydroceramide ( I ), ceramide ( J ), sphingomyelin ( K ), glucosylceramide ( L ), and lactosylceramide ( M ) in WT and Polg mice. Two-sided Student’s t test for each comparison with no adjustment for multiple comparisons. Data are means ± SEM of n = 7 to 8 animals per group. * P < 0.05, ** P < 0.01, and **** P < 0.0001.

    Article Snippet: For targeted sphingolipid analysis, 50 μl of plasma was extracted with 500 μl of −20°C methanol, 400 μl of saline, and 100 μl of water spiked with deuterated internal standards [100 pmol of D7-sphingosine (Avanti, Croda International Plc, 860657), 20 pmol of D7-sphinganine (Avanti, Croda International Plc, 860658), 2 pmol of D3-deoxysphinganine (Avanti, Croda International Plc, 860474), 200 pmol of C15 ceramide-d7 (d18:1-d7/15:0) (Avanti, Croda International Plc, 860681), 100 pmol of C13-dihydroceramide-d7 (d18:0-d7/13:0) (Avanti, Croda International Plc, 330726), 10 pmol of glucosylsphingosine (d18:1-d7) (Avanti, Croda International Plc, 860695), 100 pmol of glucosylceramide (d18:1-d7/15:0) (Avanti, Croda International Plc, 330729), 100 pmol of lactosylceramide (d18:1-d7/15:0) (Avanti, Croda International Plc, 330727), and 200 pmol of sphingomyelin (d18:1/18:1-d9) (Avanti, Croda International Plc, 791649)].

    Techniques: Concentration Assay